Japan’s Nichi-Iko Eyes $65 Million Plant To Compete In Home Generics Market
This article was originally published in PharmAsia News
Nichi-Iko Pharmaceutical of Japan plans to build a $65 million manufacturing plant to be operational by April 2013, to produce generic drugs for the domestic market.
You may also be interested in...
FDA warning to "Genesis II Church of Health and Healing " wasn't its first to the organization about promoting a chlorine dioxide formulation, "Miracle Mineral Solution," as an unapproved new drug. 'Infowars' host Alex Jones also was warned about bogus COVID-19 claims.
The first major revision since 2007 notably provides a legal foundation for special approvals under a public health crisis.
Resolution Medical teamed up with Carbon to introduce more than one million 3D-printed nasal swabs a week to address the shortage for COVID-19 testing.